Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Dimension Therapeutics, Inc. (DMTX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-16Dec-31-15Dec-31-14Jun-20-13
   10-K10-K10-K10-K
Revenues  11.57.82.82.8
            Revenue growth  48.0%181.8%  
Cost of goods sold  0.00.00.03.2
Gross profit  11.57.82.8-0.4
            Gross margin  100.0%100.0%100.0%-13.0%
Selling, general and administrative   [+]12.88.72.70.4
Research and development  47.734.013.0 
Other operating expenses     2.4
EBITDA   [+]-47.4-34.2-12.8 
            EBITDA margin  -413.2%-441.9%-465.0%-113.0%
Depreciation and amortization  1.70.70.2 
EBIT   [+]-49.1-35.0-13.0-3.2
            EBIT margin  -427.6%-451.2%-470.9%-113.0%
Interest expense, net   [+]0.00.10.0 
Other income (expense), net     3.2
Pre-tax income  -49.0-35.1-13.00.0
Income taxes  0.00.00.00.0
            Tax rate  0.0%0.0%0.0% 
Net income  -49.0-35.1-13.0-3.2
            Net margin  -427.2%-452.6%-474.1%-113.3%
   
Basic EPS   [+]($1.97)($4.41)($3.61)($2.71)
Diluted EPS   [+]($1.97)($4.41)($3.61)($2.71)
   
Shares outstanding (basic)   [+]24.97.93.61.2
Shares outstanding (diluted)   [+]24.97.93.61.2
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy